FULGENT GENETICS, INC. Cash, Including Discontinued Operations
FULGENT GENETICS, INC. (FLGT) had Cash, Including Discontinued Operations of $5.27 million as of 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Cash Flow › Cash
us-gaap:CashIncludingDiscontinuedOperations · last filed 2018-05-14
- 2018-03-31: Cash, Including Discontinued Operations $5.27M.
- 2017-12-31: Cash, Including Discontinued Operations $6.49M.
- 2017-09-30: Cash, Including Discontinued Operations $9.48M.
- 2017-06-30: Cash, Including Discontinued Operations $11.47M.
| Period end | Cash, Including Discontinued Operations |
|---|---|
| 2018-03-31 | $5.27M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $6.49M 10-Q · filed 2018-05-14 |
| 2017-09-30 | $9.48M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $11.47M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $6.73M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $7.90M 10-Q · filed 2018-05-14 |
| 2016-09-30 | $8.21M 10-Q · filed 2017-11-13 |
| 2016-06-30 | $16.06M 10-Q · filed 2017-08-14 |
| 2016-03-31 | $1.20M 10-Q · filed 2017-05-09 |
| 2015-12-31 | $498.00K 10-K · filed 2018-03-20 |
| 2015-09-30 | $1.31M 10-Q · filed 2016-11-14 |
| 2014-12-31 | $172.00K 10-K · filed 2017-03-17 |
| 2013-12-31 | $1.35M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |